Clinical significance of repeat sextant biopsies in prostate cancer patients Article Conference Paper uri icon

Overview

MeSH Major

  • Kidney Neoplasms

abstract

  • In patients with clinically localized disease, the sensitivity of SRSCB in detecting carcinoma is 80%. The results of this study highlight the potential sampling error of the SRSCB and the implication of a negative rebiopsy in patients with clinically significant prostate cancer.

publication date

  • March 1997

Research

keywords

  • Conference Paper

Identity

Digital Object Identifier (DOI)

  • 10.1016/S0090-4295(97)00178-7

PubMed ID

  • 9123730

Additional Document Info

start page

  • 113

end page

  • 8

volume

  • 49

number

  • 3 SUPPL.